SCHEMBL2301978

SCHEMBL2301978

Nc1cccc(-c2cc(N3CCNC3=O)ccc2S(=O)(=O)O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
EIF2AK2 P19525 1/20 0.36
MAPT P10636 2/20 0.34
BRD4 O60885 1/20 0.34
HTR6 P50406 2/20 0.33
GNG2 P59768 1/20 0.33
GNB1 P62873 1/20 0.33
DHODH Q02127 1/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
KMT2A Q03164 1/20 0.33
PARP1 P09874 1/20 0.33
CCNT1 O60563 1/20 0.33
CDK9 P50750 1/20 0.33
ITGB3 P05106 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2299338 0.88 HCRTR1 (0.39) EIF2AK2HTR6ALOX5APFEN1ALOX5
SCHEMBL2302675 0.88 ALOX5 (0.42) EIF2AK2MAPTHTR6MEN1LMNA
SCHEMBL2303927 0.88 EIF2AK2 (0.43) ALDH1A1EIF2AK2MAPTHTR6MEN1
SCHEMBL2304873 0.87 EIF2AK2 (0.36) EIF2AK2MAPTMEN1LMNAKMT2A
SCHEMBL14119429 0.87 POLB (0.41) EIF2AK2MEN1KMT2AALOX5
SCHEMBL2300754 0.87 ALDH1A1 (0.35) ALDH1A1TSHRHSD17B10DDB1CRBN
SCHEMBL2300656 0.84 TGFBR1 (0.40) ALDH1A1HSD17B10MAPTBRD4HTR6
SCHEMBL2303986 0.84 ALDH1A1 (0.38) ALDH1A1TSHRTDP1MAPTMEN1
SCHEMBL2304343 0.83 CCNA2 (0.33) ALDH1A1EIF2AK2MEN1KMT2AALOX5
SCHEMBL14119542 0.83 HTR6 (0.40) ALDH1A1HTR6ALOX5APFEN1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034888-B2 Substituted 2-imidazolidones and analogs UNIVERSITE LAVAL (CA) 2015-05-19 US disclosed
EP-2536693-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS Université Laval (CA) 2012-12-26 EP disclosed
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITE LAVAL (CA) 2012-12-06 US disclosed
WO-2011100840-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITé LAVAL (CA) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS CCNY, RPS4Y1, TPX2 ALDH1A1 1937/4885TSHR 171/4885HSD17B10 4591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.